BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30973842)

  • 21. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Test-Retest Variability in Lesion SUV and Lesion SUR in
    Hofheinz F; Apostolova I; Oehme L; Kotzerke J; van den Hoff J
    J Nucl Med; 2017 Nov; 58(11):1770-1775. PubMed ID: 28473598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
    Kramer GM; Frings V; Hoetjes N; Hoekstra OS; Smit EF; de Langen AJ; Boellaard R
    J Nucl Med; 2016 Sep; 57(9):1343-9. PubMed ID: 27103020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The appropriate whole body metric for calculating standardised uptake value and the influence of sex.
    Keramida G; Peters AM
    Nucl Med Commun; 2019 Jan; 40(1):3-7. PubMed ID: 30521497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normal patterns of regional brain
    Pourhassan Shamchi S; Khosravi M; Taghvaei R; Zirakchian Zadeh M; Paydary K; Emamzadehfard S; Werner TJ; Høilund-Carlsen PF; Alavi A
    Hell J Nucl Med; 2018; 21(3):175-180. PubMed ID: 30411727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of administration route, dietary condition, and blood glucose level on kinetics and uptake of 18F-FDG in mice.
    Wong KP; Sha W; Zhang X; Huang SC
    J Nucl Med; 2011 May; 52(5):800-7. PubMed ID: 21498533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between regional hepatic glucose metabolism and regional distribution of hepatic fat.
    Dunford A; Keramida G; Singh N; Aplin M; Peters AM
    Nucl Med Commun; 2019 Mar; 40(3):212-218. PubMed ID: 30628944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues.
    Paquet N; Albert A; Foidart J; Hustinx R
    J Nucl Med; 2004 May; 45(5):784-8. PubMed ID: 15136627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of standardized uptake value normalized by individual CT-based lean body mass in application of PET response criteria in solid tumors (PERCIST).
    Narita A; Shiomi S; Katayama Y; Yamanaga T; Daisaki H; Hamada K; Watanabe Y
    Radiol Phys Technol; 2016 Jul; 9(2):170-7. PubMed ID: 26873140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-FDG uptake and clearance in patients with compromised renal function.
    Akers SR; Werner TJ; Rubello D; Alavi A; Cheng G
    Nucl Med Commun; 2016 Aug; 37(8):825-32. PubMed ID: 27058366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accumulation of (18)F-FDG in the liver in hepatic steatosis.
    Keramida G; Potts J; Bush J; Verma S; Dizdarevic S; Peters AM
    AJR Am J Roentgenol; 2014 Sep; 203(3):643-8. PubMed ID: 25148170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simplified quantification of FDG metabolism in tumors using the autoradiographic method is less dependent on the acquisition time than SUV.
    Burger IA; Burger C; Berthold T; Buck A
    Nucl Med Biol; 2011 Aug; 38(6):835-41. PubMed ID: 21843779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of (18)F-fluorodeoxyglucose extravasation on time taken for tumoral uptake to reach a plateau: animal and clinical PET analyses.
    Lee JJ; Chung JH; Kim SY
    Ann Nucl Med; 2016 Oct; 30(8):525-33. PubMed ID: 27256404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of blood glucose level on 18F-FDG uptake for PET/CT in normal organs: A systematic review.
    Sprinz C; Altmayer S; Zanon M; Watte G; Irion K; Marchiori E; Hochhegger B
    PLoS One; 2018; 13(2):e0193140. PubMed ID: 29486008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans.
    Kanstrup IL; Klausen TL; Bojsen-Møller J; Magnusson P; Zerahn B
    Clin Physiol Funct Imaging; 2009 Apr; 29(2):108-13. PubMed ID: 19076727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of blood glucose level on FDG uptake by liver: a FDG-PET/CT study.
    Kubota K; Watanabe H; Murata Y; Yukihiro M; Ito K; Morooka M; Minamimoto R; Hori A; Shibuya H
    Nucl Med Biol; 2011 Apr; 38(3):347-51. PubMed ID: 21492783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions.
    Basu S; Kung J; Houseni M; Zhuang H; Tidmarsh GF; Alavi A
    Q J Nucl Med Mol Imaging; 2009 Feb; 53(1):9-19. PubMed ID: 18337683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing 18F-FDG Uptake Time Before Imaging Improves the Accuracy of PET/CT in Liver Lesions.
    Al-Faham Z; Jolepalem P; Rydberg J; Wong CY
    J Nucl Med Technol; 2016 Jun; 44(2):70-2. PubMed ID: 26966128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A bone marrow F-18 FDG uptake exceeding the liver uptake may indicate bone marrow hyperactivity.
    Inoue K; Goto R; Okada K; Kinomura S; Fukuda H
    Ann Nucl Med; 2009 Sep; 23(7):643-9. PubMed ID: 19629627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.
    Walter F; Federman N; Apichairuk W; Nelson S; Phelps ME; Allen-Auerbach M; Walter MA; Czernin J
    Pediatr Hematol Oncol; 2011 Oct; 28(7):579-87. PubMed ID: 21936620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.